Tobacco Education and Lung Health Study (TEAL)
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Feb 17, 2026 · Source: ClinicalTrials.gov
The study is currently accepting participants.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Georgetown University
- Interventions being studied
- Behavioral: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention; Behavioral: E-Referral to the Tobacco Quitline
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- eligible for a screening or diagnostic scan,
- USPSTF eligibility criteria (50-80 years old and \>20-pack years);
- currently smoking cigarettes (\>1 in the past 30 days);
- English speaking;
- able to provide meaningful consent.
- prior lung cancer,
- hearing impairment,
- cognitive impairment,
- household member already enrolled.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Georgetown University Medical CenterWashington D.C., District of Columbia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2026. Always confirm current availability with the study team.